India On Alert: Suspected Mpox Case Isolated As Testing Begins

A young male patient who recently returned from a country experiencing an Mpox (monkeypox) outbreak has been identified as a suspected case, according to the Union Health Ministry.

The patient is currently in isolation at a designated hospital and is reported to be in stable condition, as reported by Hindustan Times.

Photo Credit: Unsplash

India On Alert: Suspected Mpox Case

Mpox, a viral disease, can range from mild to severe and, in some instances, can be fatal. The Health Ministry has confirmed that samples from the patient are being tested to determine if he has contracted the virus.

In a statement, the ministry assured that the situation is under control, emphasizing that the case aligns with risk assessments previously conducted by the National Centre for Disease Control (NCDC). "There is no cause for undue concern," the ministry stated. "The country is fully prepared to handle such isolated travel-related cases and has robust measures in place to manage and mitigate potential risks," as re[prted by Hindustan Times.

The suspected case in India comes approximately three weeks after the World Health Organization (WHO) declared the Mpox outbreaks in 12 African countries a global emergency. In response, the Africa Centers for Disease Control and Prevention (Africa CDC) and the WHO have launched a comprehensive continent-wide plan. This six-month initiative, estimated to cost nearly $600 million, aims to enhance surveillance, laboratory testing, and community engagement to combat the outbreak.

As part of the response, Congo has received its first batch of 100,000 JYNNEOS vaccine doses, donated by the European Union through HERA, the EU's health emergency agency. While this is a crucial step in protecting health workers and vulnerable populations, the doses received cover only a small portion of the 3 million vaccines required to address the outbreak in Congo, the epicentre of the crisis, as per media reports.

Dr. Jean Kaseya, Africa CDC director-general, confirmed that the vaccine rollout will initially focus on adults in close contact with infected individuals and sex workers. The start date for the vaccination campaign remains uncertain, and the European Medicines Agency is evaluating the possibility of administering the vaccine to children aged 12 to 17, with a decision expected by the end of the month.